Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP618578.RARONaI2DiyqgSIxV_twj1o00_dwTWSCGne1i3sef_GzA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP618578.RARONaI2DiyqgSIxV_twj1o00_dwTWSCGne1i3sef_GzA130_assertion type Assertion NP618578.RARONaI2DiyqgSIxV_twj1o00_dwTWSCGne1i3sef_GzA130_head.
- NP618578.RARONaI2DiyqgSIxV_twj1o00_dwTWSCGne1i3sef_GzA130_assertion description "[Samples from patients with secondary AML had higher levels of MDR1 expression than those of de novo AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP618578.RARONaI2DiyqgSIxV_twj1o00_dwTWSCGne1i3sef_GzA130_provenance.
- NP618578.RARONaI2DiyqgSIxV_twj1o00_dwTWSCGne1i3sef_GzA130_assertion evidence source_evidence_literature NP618578.RARONaI2DiyqgSIxV_twj1o00_dwTWSCGne1i3sef_GzA130_provenance.
- NP618578.RARONaI2DiyqgSIxV_twj1o00_dwTWSCGne1i3sef_GzA130_assertion SIO_000772 7808005 NP618578.RARONaI2DiyqgSIxV_twj1o00_dwTWSCGne1i3sef_GzA130_provenance.
- NP618578.RARONaI2DiyqgSIxV_twj1o00_dwTWSCGne1i3sef_GzA130_assertion wasDerivedFrom befree-20150227 NP618578.RARONaI2DiyqgSIxV_twj1o00_dwTWSCGne1i3sef_GzA130_provenance.
- NP618578.RARONaI2DiyqgSIxV_twj1o00_dwTWSCGne1i3sef_GzA130_assertion wasGeneratedBy ECO_0000203 NP618578.RARONaI2DiyqgSIxV_twj1o00_dwTWSCGne1i3sef_GzA130_provenance.